Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog.
It seems that no matter how much bad press comes their way, certain pharmaceutical companies are more than happy to take a little heat to make quick...
Throughout 2017, it has emerged that the FDA has issued a record low number of warning letters to pharmaceutical firms over misrepresentation of...
Eli Lilly has unveiled Phase 3 results which reveal that its VEGF Receptor 2 antagonist Cyramza (ramucirumab) met its primary endpoint of...

Features

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out to the...

Appointments

Shortly following its announcement of...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches